Data is not available at this time.
Modern Dental Group Limited is a global manufacturer and distributor of dental prosthetic devices, operating primarily in the medical instruments and supplies sector. The company generates revenue through the production and sale of a comprehensive portfolio of dental prosthetics, including fixed devices like crowns and bridges, removable dentures, and specialized products such as orthodontic devices and sports guards. Its business model is B2B-focused, serving dentists, clinics, hospitals, and distributors across Europe, Greater China, North America, and Australia through a multi-brand strategy that includes Permadental, Schmidt, and Modern Dental Laboratory. This diversified geographic and product approach mitigates regional economic risks while leveraging cross-selling opportunities. Modern Dental occupies a solid position as an integrated solutions provider in the outsourced dental lab market, competing on scale, technical expertise, and a broad service footprint. The company benefits from long-term demographic trends like aging populations and increasing dental health awareness, though it operates in a competitive and fragmented industry where technological adoption and cost efficiency are critical to maintaining margin strength.
The company reported revenue of HKD 3.36 billion with net income of HKD 408 million, reflecting a net margin of approximately 12.1%. Operating cash flow was strong at HKD 479 million, significantly exceeding capital expenditures, indicating healthy cash generation from core operations and efficient working capital management.
Diluted earnings per share stood at HKD 0.43, demonstrating the firm’s ability to translate top-line performance into shareholder returns. Operating cash flow of HKD 479 million, against capital expenditures of HKD 142 million, highlights robust free cash flow generation and efficient reinvestment into the business for sustained growth.
Modern Dental maintains a conservative financial structure with cash and equivalents of HKD 817 million against total debt of HKD 924 million. This indicates a solid liquidity position and moderate leverage, supporting operational flexibility and potential strategic investments without significant financial strain.
The company has demonstrated a commitment to returning capital to shareholders, with a dividend per share of HKD 0.21. This payout, coupled with underlying earnings growth, reflects a balanced approach between reinvestment for expansion and providing consistent income returns to investors.
With a market capitalization of approximately HKD 5.08 billion and a P/E ratio derived from trailing earnings, the market appears to value the company in line with its sector peers. A beta of 1.29 suggests higher volatility than the market, potentially pricing in both growth opportunities and operational risks inherent in its global footprint.
The group’s key strengths include its diversified geographic presence, multi-brand strategy, and comprehensive product portfolio. Looking ahead, its ability to leverage demographic tailwinds and technological advancements in digital dentistry will be crucial for maintaining competitive advantage and driving long-term shareholder value.
Company Annual ReportHong Kong Stock Exchange Filings
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |